Johnson Johnson submits application to conduct bridge trial of its single-dose COVID-19 vaccine in India

“Johnson Johnson is partnering with health authorities and the world’s best scientists to provide the safety and efficacy data necessary to support worldwide emergency use of the Janssen COVID-19 vaccine candidate," the company said in a statement to Moneycontrol.

from Moneycontrol Business News https://ift.tt/3v9rmqz